“Prof Itescu said that after the company ran through the data with the FDA in person it was able to win over the regulatory body. ”
I reckon he’s posting about that article in The Australian a few short weeks ago.
No one listens to Itescu. Not the market. Not you. Not the FDA. No Novartis.
2024 Here we go again., page-868
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.8¢ |
Change
0.003(0.27%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 92.5¢ | $534.1K | 572.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 210481 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 67359 | 24 |
View Market Depth
| Last trade - 12.10pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |